Thinking of joining a study?

Register your interest

NCT05556967 | Completed | Adherence, Patient


Identification of Surrogate Blood and/or Urine Biomarker for Immulina TM (Trademark) in Normal Humans
Sponsor:

University of Mississippi Medical Center

Brief Summary:

This is a pilot study for identifying plasma and/or urine-derived adherence/surrogate biomarker candidates for verifying Immulina™ ingestion by human volunteers (collected before and after consumption of Immulina™, a natural dietary supplement).

Condition or disease

Adherence, Patient

Intervention/treatment

Immulina

Phase

Not Applicable

Detailed Description:

This pilot study is interventional, and all participants will receive one 800 mg dose of Immulina™ (four 200 mg capsules), a natural supplement, after a baseline blood and urine collection, then follow with 1 hour, 3 hour and 6 hour post-Immulina™ blood and urine collections. Samples will be sent to UM National Center for Natural Products Research (NCNPR) to analyze and compare timed blood and urine samples using gas chromatography and liquid chromatography to detect volatile and non-volatile compounds, gamma-linolenic acid (GLA), sulfoquinovose (SQ), 5'-methylsulfinyladenosine (MSA), palmitic acid, linoleic acid, palmitoleic acid and oleic acid to screen the chemical fingerprints of the human samples. The mean of the 7 biomarkers for the 4 time points will be measured and compared.}}

Study Type : Interventional
Estimated Enrollment : 20 participants
Masking : None (Open Label)
Primary Purpose : Basic Science
Official Title : Identification of Surrogate Blood and/or Urine Biomarker for Immulina TM in Normal Humans
Actual Study Start Date : August 9, 2023
Estimated Primary Completion Date : October 19, 2023
Estimated Study Completion Date : October 19, 2023
Arm Intervention/treatment

Experimental: Immulina Dietary Supplementation

Immulina Dietary Supplementation (200 mg per capsule) 4-200 mg capsules given by mouth once on the only study visit day.

Dietary Supplement: Immulina

Ages Eligible for Study: 18 Years to 50 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Accepts Healthy Volunteers
Criteria
Inclusion Criteria
  • Males and females, 18-50 years old
  • If female of childbearing potential, using acceptable means of birth control or postmenopausal for at least two years
  • Healthy
Exclusion Criteria
  • pregnant or lactating females
  • significant acute disease
  • recurrent medications for chronic disease

Identification of Surrogate Blood and/or Urine Biomarker for Immulina TM (Trademark) in Normal Humans

Location Details


Please Choose a site



Identification of Surrogate Blood and/or Urine Biomarker for Immulina TM (Trademark) in Normal Humans

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

United States, Mississippi

Clinical Research and Trials Unit - University of Mississippi Medical Center

Jackson, Mississippi, United States, 39216

Loading...